Cascade Completed a New Round of Financing to Accelerate Clinical Research of Primary Research Products for Metabolic Diseases

With Another Financing of Nearly 100 Million Yuan, Cascade Accelerated Its Competition for Nuclear Receptor and GPCR Innovative Drug Research and Development

Accelerating the Development of New Drugs, Cascade Obtained Nearly 100 Million Yuan of Pre-A round of Financing